| 000 | 01289 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517193740.0 | ||
| 264 | 0 | _c20190708 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1755-3245 | ||
| 024 | 7 |
_a10.1093/cvr/cvx248 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKusters, Pascal J H | |
| 245 | 0 | 0 |
_aExploring immune checkpoints as potential therapeutic targets in atherosclerosis. _h[electronic resource] |
| 260 |
_bCardiovascular research _c03 2018 |
||
| 300 |
_a368-377 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArteries _xdrug effects |
| 650 | 0 | 4 |
_aAtherosclerosis _xdrug therapy |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aInflammation Mediators _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aPlaque, Atherosclerotic |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aLutgens, Esther | |
| 700 | 1 | _aSeijkens, Tom T P | |
| 773 | 0 |
_tCardiovascular research _gvol. 114 _gno. 3 _gp. 368-377 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cvr/cvx248 _zAvailable from publisher's website |
| 999 |
_c27956252 _d27956252 |
||